Clinical Trial Update: carDIo-ttranSSfOrm nucLEar Imaging Study

View source ↗

Summary

The carDIo-ttranSSfOrm nucLEar Imaging Study, sponsored by Oregon Health and Science University, has been terminated. The study involves amyloidosis and transth…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyloidosis
• Transthyretin Amyloid Cardiomyopathy

Snippet

Sponsor: Oregon Health and Science University | Conditions: Amyloidosis, Transthyretin Amyloid Cardiomyopathy | Status: TERMINATED